Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Defactinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verastem Announces FDA Acceptance for Avutometinib in Ovarian Cancer
    Verastem Announces FDA Acceptance for Avutometinib in Ovarian Cancer

    30 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241230294719/en

    BUSINESSWIRE
    30 Dec 2024
    Share Share
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer
    Verastem Complete NDA Submission for Avutometinib in Ovarian Cancer

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031747822/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024
    Verastem Announces RAMP 201 Data Oral Presentation At IGCS 2024

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009704485/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer
    Verastem Receives FDA Orphan Drug Designation For Pancreatic Cancer

    29 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240729473398/en

    BUSINESSWIRE
    29 Jul 2024
    Share Share
    Verastem's begins rolling sub of NDA to USFDA of avutometinib & defactinib combo
    Verastem's begins rolling sub of NDA to USFDA of avutometinib & defactinib combo

    28 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169383&sid=2

    PHARMABIZ
    28 May 2024
    Share Share
    Verastem Nda Initiation: Avutometinib Defactinib Combo Rolling Submission
    Verastem Nda Initiation: Avutometinib Defactinib Combo Rolling Submission

    24 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240524990712/en

    BUSINESSWIRE
    24 May 2024
    Share Share